TY - JOUR
T1 - Lymphoid tissue fibrosis is associated with impaired vaccine responses
AU - Kityo, Cissy
AU - Makamdop, Krystelle Nganou
AU - Rothenberger, Meghan
AU - Chipman, Jeffrey G.
AU - Hoskuldsson, Torfi
AU - Beilman, Gregory J.
AU - Grzywacz, Bartosz
AU - Mugyenyi, Peter
AU - Ssali, Francis
AU - Akondy, Rama S.
AU - Anderson, Jodi
AU - Schmidt, Thomas E.
AU - Reimann, Thomas
AU - Callisto, Samuel P.
AU - Schoephoerster, Jordan
AU - Schuster, Jared
AU - Muloma, Proscovia
AU - Ssengendo, Patrick
AU - Moysi, Eirini
AU - Petrovas, Constantinos
AU - Lanciotti, Ray
AU - Zhang, Lin
AU - Arévalo, Maria T.
AU - Rodriguez, Benigno
AU - Ross, Ted M.
AU - Trautmann, Lydie
AU - Sekaly, Rafick Pierre
AU - Lederman, Michael M.
AU - Koup, Richard A.
AU - Ahmed, Rafi
AU - Reilly, Cavan
AU - Douek, Daniel C.
AU - Schacker, Timothy W.
N1 - Publisher Copyright:
© 2018 American Society for Clinical Investigation. All rights reserved.
PY - 2018/7/2
Y1 - 2018/7/2
N2 - Vaccine responses vary by geographic location. We have previously described how HIV-associated inflammation leads to fibrosis of secondary lymph nodes (LNs) and T cell depletion. We hypothesized that other infections may cause LN inflammation and fibrosis, in a process similar to that seen in HIV infection, which may lead to T cell depletion and affect vaccine responses. We studied LNs of individuals from Kampala, Uganda, before and after yellow fever vaccination (YFV) and found fibrosis in LNs that was similar to that seen in HIV infection. We found blunted antibody responses to YFV that correlated to the amount of LN fibrosis and loss of T cells, including T follicular helper cells. These data suggest that LN fibrosis is not limited to HIV infection and may be associated with impaired immunologic responses to vaccines. This may have an impact on vaccine development, especially for infectious diseases prevalent in the developing world.
AB - Vaccine responses vary by geographic location. We have previously described how HIV-associated inflammation leads to fibrosis of secondary lymph nodes (LNs) and T cell depletion. We hypothesized that other infections may cause LN inflammation and fibrosis, in a process similar to that seen in HIV infection, which may lead to T cell depletion and affect vaccine responses. We studied LNs of individuals from Kampala, Uganda, before and after yellow fever vaccination (YFV) and found fibrosis in LNs that was similar to that seen in HIV infection. We found blunted antibody responses to YFV that correlated to the amount of LN fibrosis and loss of T cells, including T follicular helper cells. These data suggest that LN fibrosis is not limited to HIV infection and may be associated with impaired immunologic responses to vaccines. This may have an impact on vaccine development, especially for infectious diseases prevalent in the developing world.
UR - http://www.scopus.com/inward/record.url?scp=85049859039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049859039&partnerID=8YFLogxK
U2 - 10.1172/JCI97377
DO - 10.1172/JCI97377
M3 - Article
C2 - 29781814
AN - SCOPUS:85049859039
SN - 0021-9738
VL - 128
SP - 2763
EP - 2773
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 7
ER -